CJC-1295 (no DAC) vs Ipamorelin
CJC-1295 (no DAC) and Ipamorelin are both stocked here and are often considered together. This page sets out what differs between them: their class, the sizes and price per milligram, the shape of the published evidence behind each, and where each stands under Canadian law. It does not rank them, because which is appropriate depends on what is being studied.
Side by side
| CJC-1295 (no DAC) | Ipamorelin | |
|---|---|---|
| Class | Growth hormone-releasing hormone (GHRH) analogue | Growth hormone secretagogue (ghrelin receptor agonist) |
| Sizes and price | 10 mg — from $38.00 (best $3.80/mg) | 10 mg — from $62.00 (best $6.20/mg) |
| Published evidence | 6 cited studies; 1 controlled trial in people. | 8 cited studies; 1 controlled trial in people. |
| Models studied | rat, rat anterior pituitary membranes, in vitro structure-activity study of hgrf-nh2 analogues | human, primary rat pituitary cells, rat |
| Status in Canada | No Drug Identification Number; named in a Health Canada advisory | No Drug Identification Number; named in a Health Canada advisory |
| Formats | vial, starter | vial, starter |
Key differences
CJC-1295 (no DAC) 6 cited studies; 1 controlled trial in people. Ipamorelin 8 cited studies; 1 controlled trial in people.
No published study has compared CJC-1295 (no DAC) and Ipamorelin directly. Everything above is drawn from separate studies of each compound, so the two columns are not results from one experiment.
Both are supplied for in-vitro laboratory research only and neither is for human or veterinary use.
FAQ
What is the difference between CJC-1295 (no DAC) and Ipamorelin?
CJC-1295 (no DAC) is growth hormone-releasing hormone (ghrh) analogue; Ipamorelin is growth hormone secretagogue (ghrelin receptor agonist). The table above sets out the sizes, the price per milligram, the evidence behind each and their Canadian status.
Which has more published research, CJC-1295 (no DAC) or Ipamorelin?
CJC-1295 (no DAC) has 6 cited studies on its page and Ipamorelin has 8. Study count is not quality: the model each one used matters more, and both pages list that for every paper.
Are CJC-1295 (no DAC) and Ipamorelin authorized in Canada?
No Drug Identification Number; named in a Health Canada advisory for CJC-1295 (no DAC). No Drug Identification Number; named in a Health Canada advisory for Ipamorelin. Health Canada authorizes a drug by issuing an eight-digit Drug Identification Number, and most research peptides have none.
Can CJC-1295 (no DAC) and Ipamorelin be used together?
No published study has tested them in combination, so there is no evidence about what a pairing does. We supply both for laboratory research and make no claim about using them together.